205 related articles for article (PubMed ID: 15906048)
1. A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?
Tanaka Y; Yokoo H; Komori T; Makita Y; Ishizawa T; Hirose T; Ebato M; Shibahara J; Tsukayama C; Shibuya M; Nakazato Y
Acta Neuropathol; 2005 Jul; 110(1):39-47. PubMed ID: 15906048
[TBL] [Abstract][Full Text] [Related]
2. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
[TBL] [Abstract][Full Text] [Related]
3. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
4. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
5. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
6. Papillary glioneuronal tumor with minigemistocytic components and increased proliferative activity.
Ishizawa T; Komori T; Shibahara J; Ishizawa K; Adachi J; Nishikawa R; Matsutani M; Hirose T
Hum Pathol; 2006 May; 37(5):627-30. PubMed ID: 16647962
[TBL] [Abstract][Full Text] [Related]
7. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
8. Papillary glioneuronal tumor: a case report and review of the literature.
Williams SR; Joos BW; Parker JC; Parker JR
Ann Clin Lab Sci; 2008; 38(3):287-92. PubMed ID: 18715860
[TBL] [Abstract][Full Text] [Related]
9. Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes.
Tatsumi K; Takebayashi H; Manabe T; Tanaka KF; Makinodan M; Yamauchi T; Makinodan E; Matsuyoshi H; Okuda H; Ikenaka K; Wanaka A
J Neurosci Res; 2008 Dec; 86(16):3494-502. PubMed ID: 18816798
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of glial and neuronal markers in the neurocytic rosettes of rosette-forming glioneuronal tumors.
Matsumura N; Wang Y; Nakazato Y
Brain Tumor Pathol; 2014 Jan; 31(1):17-22. PubMed ID: 23329202
[TBL] [Abstract][Full Text] [Related]
11. Low grade diffuse gliomas: shared cellular composition and morphometric differences.
Kinjo S; Hirato J; Nakazato Y
Neuropathology; 2008 Oct; 28(5):455-65. PubMed ID: 18282166
[TBL] [Abstract][Full Text] [Related]
12. Bilateral non-contiguous atypical papillary glioneuronal tumor: case report.
Flannery T; Purce A; Harney J; McKinstry S; Ironside JW; Herron B
Clin Neuropathol; 2012; 31(2):77-80. PubMed ID: 22385788
[TBL] [Abstract][Full Text] [Related]
13. Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.
Yokoo H; Nobusawa S; Takebayashi H; Ikenaka K; Isoda K; Kamiya M; Sasaki A; Hirato J; Nakazato Y
Am J Pathol; 2004 May; 164(5):1717-25. PubMed ID: 15111318
[TBL] [Abstract][Full Text] [Related]
14. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
[TBL] [Abstract][Full Text] [Related]
15. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
Ikota H; Kinjo S; Yokoo H; Nakazato Y
Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
[TBL] [Abstract][Full Text] [Related]
16. Evidence that nucleocytoplasmic Olig2 translocation mediates brain-injury-induced differentiation of glial precursors to astrocytes.
Magnus T; Coksaygan T; Korn T; Xue H; Arumugam TV; Mughal MR; Eckley DM; Tang SC; Detolla L; Rao MS; Cassiani-Ingoni R; Mattson MP
J Neurosci Res; 2007 Aug; 85(10):2126-37. PubMed ID: 17510983
[TBL] [Abstract][Full Text] [Related]
17. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.
Phi JH; Park SH; Kim SK; Paek SH; Kim JH; Lee YJ; Cho BK; Park CK; Lee DH; Wang KC
Am J Surg Pathol; 2008 Jan; 32(1):103-12. PubMed ID: 18162777
[TBL] [Abstract][Full Text] [Related]
18. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
19. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]